PERCUTANEOUS NEPHROSTOMY FOR OBSTRUCTIVE UROPATHY MANAGEMENT IN CERVICAL CARCINOMA

##plugins.themes.bootstrap3.article.main##

##plugins.themes.bootstrap3.article.sidebar##

PDF
Published 2022-04-28
Muhlis Yusuf Niwanda Yogiswara Soetojo

Abstract

Objective: This study aims to evaluate the role of percutaneous nephrostomy (PCN) in treating patients with hydronephrosis due to complications of cervical cancer. Material & Methods: This research was a retrospective analytical cohort study. All medical record data of patients with a diagnosis of cervical carcinoma and undergoing percutaneous nephrostomy at Soetomo General Hospital in 2017 – 2020 were collected and analyzed. Results: A total of 45 subjects were included in this research. The mean age of the subjects was 55.07, with the youngest being 34 years old and the oldest being 75 years old. Most of the subjects were stage IIIB cervical carcinoma (95.56%), and the rest were stage IIB. Contralateral PCN was required in 75.56% of subjects, and the rest only required unilateral PCN. Before being PCN performed, some patients had moderate HN (64.4%), and after the patients underwent PCN procedure, the majority of patients had the HN resolved (48.89%) (p<0.05). There was also an improvement in the laboratory parameter of urea and creatinine serum before and after PCN (p<0.05). Conclusion: PCN  improves the laboratory and radiologic parameters of cervical cancer patients with hydronephrosis.


##plugins.themes.bootstrap3.article.details##

Keywords

Cervix cancer, percutaneous nephrostomy, hydronephrosis, survival, mortality

References

Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021; 71(3): 209–49.

Cohen PA, Jhingran A, Oaknin A, Denny L. Cervical cancer. Lancet. 2019; 393(10167): 169–82.

Goklu MR, Seckin KD, Togrul C, Goklu Y, Tahaoglu AE, Oz M, et al. Effect of hydronephrosis on survival in advanced stage cervical cancer. Asian Pacific J Cancer Prev. 2015; 16(10): 4219–22.

Patel K, Foster NR, Kumar A, Grudem M, Longenbach S, Bakkum-Gamez J, et al. Hydronephrosis in patients with cervical cancer: an assessment of morbidity and survival. Support Care Cancer. 2015; 23(5): 1303–9.

Souza ACP de, Souza AN, Kirsztajn R, Kirsztajn GM. Cervical cancer: Renal complications and survival after percutaneous nephrostomy. Rev Assoc Med Bras. 2016; 62: 255–61.

Van Aardt MC, Van Aardt J, Mouton A. Impact of percutaneous nephrostomy in South African women with advanced cervical cancer and obstructive uropathy. South African J Gynaecol Oncol. 2017; 9(1): 19–23.

Mishra K, Desai A, Patel S, Mankad M, Dave K. Role of percutaneous nephrostomy in advanced cervical carcinoma with obstructive uropathy: A case series. Indian J Palliat Care. 2009; 15(1): 37.

Whitley E, Ball J. Statistics review 6: Nonparametric methods. Crit care. 2002; 6(6): 1–5.

Bilge I. Symptomatology and Clinic of Hydronephrosis Associated With Uretero Pelvic Junction Anomalies. Frontiers in Pediatrics. 2020; 8.

Keddis MT, Rule AD. Nephrolithiasis and loss of kidney function. Vol. 22, Current Opinion in Nephrology and Hypertension. 2013. p. 390–6.

Pergialiotis V, Bellos I, Thomakos N, Haidopoulos D, Perrea DN, Kontzoglou K, et al. Survival outcomes of patients with cervical cancer and accompanying hydronephrosis: A systematic review of the literature. Oncology Reviews. 2019; 13: 23–9.

Sowunmi AC, Ajekigbe AT, Alabi AO, Popoola AO, Fatiregun OA, Akinyanju AM. Incidence of Hydronephrosis in Cervical Cancer Patients in A Tertiary Hospital Lagog, Nigeria. Nig Q J Hosp Med. 2015; 25(3): 171–6.

Ku JH, Lee SW, Jeon HG, Kim HH, Oh S-J. Percutaneous nephrostomy versus indwelling ureteral stents in the management of extrinsic ureteral obstruction in advanced malignancies: are there differences? Urology. 2004; 64(5): 895–9.

Shehab M, El Helali A, Abdelkhalek M, Abdelshafy M, Mourad M, El Helaly H, et al. Role of ureteric stents in relieving obstruction in patients with obstructive uropathy. Urol Ann. 2013; 5(3): 148–51.

McPhail S, Johnson S, Greenberg D, Peake M, Rous B. Stage at diagnosis and early mortality from cancer in England. Br J Cancer. 2015; 112(1): S108–15.

Section
Articles
Copyright Information
Department of Urology, Faculty of Medicine/Airlangga University